Trial intelligence / Profile preview

Marcaine temperature and shivering during cesarean section

IRCT20210816052206N1Phase 3Completed

Sponsor
Shahid Sadoughi University of Medical Sciences
Start
Dec 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial of bupivacaine (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoint: Shivering severity during and after cesarean section. Started Dec 2021; status: completed.

02

Drugs

bupivacaine

Beyond the preview

Go deeper on IRCT20210816052206N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210816052206N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call